Biovie (BIVI) Share-based Compensation (2013 - 2026)
Biovie (BIVI) recorded Share-based Compensation of $256,719 in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 27.2% from $352,809 a year earlier and down 83.6% from the prior quarter.
Powered by 
Analysis
Biovie (BIVI) Share-based Compensation (2013 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Biovie reported Share-based Compensation of $2.28 million, up 91.0% from FY2025.
- Annual Share-based Compensation has a five-year compound annual growth rate of -5.4% (FY2021 to FY2026).
- Across earlier fiscal years, Share-based Compensation came in at $1.2 million in FY2025 (-57.7%), $2.82 million in FY2024 (-33.1%), $4.22 million in FY2023 (-27.3%) and $5.81 million in FY2022 (+92.3%).
- Quarterly Share-based Compensation has ranged from $118,898 in fiscal Q1 2025 to $4 million in fiscal Q1 2023 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in 1 of the last six quarters, with an average decline of 20.6%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 165.5% in fiscal Q4 2022, against a decline of 85.3% in fiscal Q1 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $1.56 million (Q3 2026), $197,336 (Q2 2026) and $268,388 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Biovie | 9.06 Mn | -58.54 Mn | - | 256,719.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 256,719.00 |
| Mar 31, 2026 | 1.56 Mn |
| Dec 31, 2025 | 197,336.00 |
| Sep 30, 2025 | 268,388.00 |
| Jun 30, 2025 | 352,809.00 |
| Mar 31, 2025 | 338,412.00 |
| Dec 31, 2024 | 385,328.00 |
| Sep 30, 2024 | 118,898.00 |
| Jun 30, 2024 | 705,115.00 |
| Mar 31, 2024 | 690,921.00 |
| Dec 31, 2023 | 619,701.00 |
| Sep 30, 2023 | 808,027.00 |
| Jun 30, 2023 | 742,420.00 |
| Mar 31, 2023 | 888,998.00 |
| Dec 31, 2022 | 1.71 Mn |
| Sep 30, 2022 | 878,640.00 |
| Jun 30, 2022 | 1.80 Mn |
| Mar 31, 2022 | 930,334.00 |
| Dec 31, 2021 | 1.15 Mn |
| Sep 30, 2021 | 1.93 Mn |
API Access
Biovie Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BIVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BIVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BIVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();